+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

First recorded outbreaks of meningococcal disease in the Israel defence force: Three clusters due to serogroup C and the emergence of resistance to rifampicin

First recorded outbreaks of meningococcal disease in the Israel defence force: Three clusters due to serogroup C and the emergence of resistance to rifampicin

Infection 22(2): 69-71

Outbreaks of meningococcal disease were observed for the first time in the Israel Defence Force (I.D.F.) in 1992 and 1993, while in previous years, cases appeared in sporadic fashion. Two episodes in the winter of 1992 involving three and two individuals, respectively, were caused by Neisseria meningitidis group C, which was nontypable and nonsubtypable (C:NT:-). Three cases in one event in early 1993 were due to group C:NT:P1.2, the two secondary cases being caused by strains completely resistant to rifampicin. While these outbreaks were small, they should be seen against a background of the emergence of relatively virulent clones of serogroup C which have caused significant outbreaks in several countries. This and the drug resistance problem will require medical decision-makers to review strategies for the prevention of meningococcal disease, taking into account alternative agents for chemoprophylaxis as well as a possible role for vaccination.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 008688729

Download citation: RISBibTeXText

PMID: 8070932

DOI: 10.1007/bf01739006

Related references

Evidence for the emergence of serogroup Y meningococcal disease in South Africa and hyperendemnicity of serogroup B in the southern parts of the country. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 273, 2001

Serogroup B meningococcal disease: new outbreaks, new strategies. JAMA 281(16): 1541-1543, 1999

No evidence of clusters of serogroup C meningococcal disease in the Dutch MSM community. Journal of Infection 68(3): 296-297, 2014

Meningococcal disease--management of serogroup C clusters in a hyperendemic area. Irish Medical Journal 94(6): 166 168-9, 2001

Prevention and control of meningococcal outbreaks: The emerging role of serogroup B meningococcal vaccines. Vaccine 33(31): 3628-3635, 2015

Emergence of serogroup X meningococcal disease in Africa: need for a vaccine. Vaccine 31(27): 2852-2861, 2013

Recent emergence of serogroup C meningococcal disease in Greece. FEMS Immunology & Medical Microbiology 23(1): 49-55, 1999

Rapid laboratory detection of meningococcal disease outbreaks caused by serogroup C Neisseria meningitidis. Journal of Microbiological Methods 67(2): 330-338, 2006

Carriage rate and effects of vaccination after outbreaks of serogroup C meningococcal disease, Brazil, 2010. Emerging Infectious Diseases 20(5): 806-811, 2014

Functional T-cell deficiency in adolescents who experience serogroup C meningococcal disease despite receiving the meningococcal serogroup C conjugate vaccine. Clinical and Vaccine Immunology 17(7): 1104-1110, 2010

Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015. Mmwr. Morbidity and Mortality Weekly Report 64(22): 608-612, 2015

Usefulness of pulsed-field gel electrophoresis in tracking two outbreaks of invasive meningococcal disease serogroup C in British Columbia. Canadian Journal of Infectious Diseases and Medical Microbiology 18(6): 363-367, 2007

Emergence of serogroup C meningococcal disease associated with a high mortality rate in Hefei, China. Bmc Infectious Diseases 12: 205, 2012